Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 42, 2977-2979, August 1, 1982]
© 1982 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Eckhardt, A. E.
Right arrow Articles by Goldstein, I. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Eckhardt, A. E.
Right arrow Articles by Goldstein, I. J.

Inhibition of Ehrlich Ascites Tumor Cell Growth by Griffonia simplicifolia I Lectin in Vivo1

Allen E. Eckhardt2, Barbara N. Malone and Irwin J. Goldstein3

Department of Biological Chemistry, University of Michigan, Ann Arbor, Michigan 48109

Griffonia (Bandeiraea) simplicifolia I (GS I) seeds contain a family of {alpha}-D-galactopyranosyl-binding isolectins which strongly agglutinate Ehrlich ascites tumor cells due to the presence of this determinant sugar on their cell surface glycoproteins. Administration of GS I lectin (100 µg/day or 300 µg on alternate days, i.p.) inhibits the growth of Ehrlich tumor cells in vivo. Mice given injections of only Ehrlich cells lived an average of 36 ± 13 (S.E.) days with no mouse surviving longer than 53 days. Mice given injections of Ehrlich cells and 100 µg GS I lectin daily or 300 µg GS I lectin on alternate days showed 75 and 62% survival, respectively, after 60 days. Lectin-dependent, macrophage-mediated tumor cell lysis may be the mechanism whereby the GS I lectin exerts its cytotoxic effect.

1 This investigation was supported by USPHS Grant CA20424 awarded by the National Cancer Institute, Department of Health and Human Services, and Institutional Grant 341387 from the American Cancer Society.

2 Present address: Department of Biochemistry, Duke University Medical Center, Durham, N. C. 27710.

3 To whom requests for reprints should be addressed.

Received 9/10/81. Accepted 4/26/82.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1982 by the American Association for Cancer Research.